Brazil · Delayed Price · Currency is BRL Dexco Statistics
Total Valuation
Dexco has a market cap or net worth of BRL 4.70 billion. The enterprise value is 11.14 billion.
| Market Cap | 4.70B |
| Enterprise Value | 11.14B |
Important Dates
The last earnings date was Wednesday, August 6, 2025.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | Mar 18, 2025 |
Share Statistics
Dexco has 810.40 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Current Share Class | 810.40M |
| Shares Outstanding | 810.40M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 12.86% |
| Owned by Institutions (%) | 28.45% |
| Float | 397.10M |
Valuation Ratios
The trailing PE ratio is 24.43 and the forward PE ratio is 28.11. Dexco's PEG ratio is 1.01.
| PE Ratio | 24.43 |
| Forward PE | 28.11 |
| PS Ratio | 0.56 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.79 |
| P/FCF Ratio | 80.23 |
| P/OCF Ratio | 4.26 |
| PEG Ratio | 1.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.34, with an EV/FCF ratio of 190.23.
| EV / Earnings | 57.89 |
| EV / Sales | 1.34 |
| EV / EBITDA | 6.34 |
| EV / EBIT | 19.99 |
| EV / FCF | 190.23 |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 1.11.
| Current Ratio | 1.22 |
| Quick Ratio | 0.77 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | 5.03 |
| Debt / FCF | 134.09 |
| Interest Coverage | 0.44 |
Financial Efficiency
Return on equity (ROE) is 3.09% and return on invested capital (ROIC) is 1.52%.
| Return on Equity (ROE) | 3.09% |
| Return on Assets (ROA) | 1.24% |
| Return on Invested Capital (ROIC) | 1.52% |
| Return on Capital Employed (ROCE) | 2.58% |
| Revenue Per Employee | 585,287 |
| Profits Per Employee | 13,531 |
| Employee Count | 14,228 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 3.90 |
Taxes
| Income Tax | -16.56M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.75% in the last 52 weeks. The beta is 0.34, so Dexco's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -28.75% |
| 50-Day Moving Average | 5.60 |
| 200-Day Moving Average | 5.87 |
| Relative Strength Index (RSI) | 58.23 |
| Average Volume (20 Days) | 1,468,590 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dexco had revenue of BRL 8.33 billion and earned 192.52 million in profits. Earnings per share was 0.24.
| Revenue | 8.33B |
| Gross Profit | 1.93B |
| Operating Income | 360.28M |
| Pretax Income | 195.57M |
| Net Income | 192.52M |
| EBITDA | 1.51B |
| EBIT | 360.28M |
| Earnings Per Share (EPS) | 0.24 |
Balance Sheet
The company has 1.48 billion in cash and 7.86 billion in debt, giving a net cash position of -6.20 billion or -7.66 per share.
| Cash & Cash Equivalents | 1.48B |
| Total Debt | 7.86B |
| Net Cash | -6.20B |
| Net Cash Per Share | -7.66 |
| Equity (Book Value) | 7.05B |
| Book Value Per Share | 8.40 |
| Working Capital | 894.79M |
Cash Flow
In the last 12 months, operating cash flow was 1.10 billion and capital expenditures -1.05 billion, giving a free cash flow of 58.59 million.
| Operating Cash Flow | 1.10B |
| Capital Expenditures | -1.05B |
| Free Cash Flow | 58.59M |
| FCF Per Share | 0.07 |
Margins
Gross margin is 23.14%, with operating and profit margins of 4.33% and 2.31%.
| Gross Margin | 23.14% |
| Operating Margin | 4.33% |
| Pretax Margin | 2.35% |
| Profit Margin | 2.31% |
| EBITDA Margin | 18.11% |
| EBIT Margin | 4.33% |
| FCF Margin | 0.70% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 3.71%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 3.71% |
| Dividend Growth (YoY) | -81.61% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 121.45% |
| Buyback Yield | -0.06% |
| Shareholder Yield | 3.75% |
| Earnings Yield | 4.10% |
| FCF Yield | 1.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 21, 2022. It was a forward split with a ratio of 1.1.
| Last Split Date | Dec 21, 2022 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
Dexco has an Altman Z-Score of 1.07 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.07 |
| Piotroski F-Score | 6 |